Back
Kymera Therapeutics Stock Price Chart
BRICS Plans to End US Dollar Dominance
Learn More
Buy
54
KYMR
Kymera Therapeutics
Last Price:
44.79
Seasonality Move:
25.63%
7 Day Trial
ALL ACCESS PASS
$
7
#1 free indicator forecasts the next market drop here
Discover my #1 trading indicator here.- The current trend is moderately bearish and KYMR is experiencing selling pressure, which indicates risk of future bearish movement.
Kymera Therapeutics Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 46.33 | Sell |
| 20-day SMA: | 46.49 | Sell |
| 50-day SMA: | 43.27 | Buy |
| 200-day SMA: | 35.7 | Buy |
| 8-day EMA: | 46.22 | Sell |
| 20-day EMA: | 45.92 | Sell |
| 50-day EMA: | 43.32 | Buy |
| 200-day EMA: | 36.21 | Buy |
Kymera Therapeutics Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.88 | Buy |
| Relative Strength Index (14 RSI): | 48.13 | Sell |
| Chaikin Money Flow: | -245093 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (43.03 - 48.09) | Sell |
| Bollinger Bands (100): | (32.8 - 44.58) | Buy |
Kymera Therapeutics Technical Analysis
| Aug 28 | Aug 29 | Aug 30 | Sep 3 | Sep 4 | Sep 5 | Sep 6 | Sep 9 | Sep 10 | Sep 11 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Aug | Sep | |||||||||
| 28 | 29 | 30 | 03 | 04 | 05 | 06 | 09 | 10 | 11 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Kymera Therapeutics Stock
Is Kymera Therapeutics Stock a Buy?
- Kymera Therapeutics share price is 44.77 while KYMR 8-day simple moving average is 46.33, which is a Sell signal.
- The stock price of KYMR is 44.77 while Kymera Therapeutics 20-day SMA is 46.49, which makes it a Sell.
- Kymera Therapeutics 50-day simple moving average is 43.27 while KYMR share price is 44.77, making it a Buy technically.
- KYMR stock price is 44.77 and Kymera Therapeutics 200-day simple moving average is 35.70, creating a Buy signal.
KYMR Technical Analysis vs Fundamental Analysis
Buy
54
Kymera Therapeutics (KYMR)
is a Buy
Is Kymera Therapeutics a Buy or a Sell?
-
Kymera Therapeutics stock is rated a Buy
The current Kymera Therapeutics [KYMR] share price is $44.77. The Score for KYMR is 54, which is 8% above its historic median score of 50, and infers lower risk than normal.
Kymera Therapeutics Stock Info
Market Cap:
2.76B
Price in USD:
44.77
Share Volume:
275.65K
Kymera Therapeutics 52-Week Range
52-Week High:
50.19
52-Week Low:
9.60
Buy
54
Kymera Therapeutics (KYMR)
is a Buy
Kymera Therapeutics Share Price Forecast
-
What is the Kymera Therapeutics stock price today?
The Kymera Therapeutics stock price is 44.77 USD today. -
Will KYMR stock go up or go down?
Kymera Therapeutics> share price is forecast to RISE/FALL based on technical indicators -
Is Kymera Therapeutics overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, Kymera Therapeutics is not overvalued.
Is Kymera Therapeutics Stock a Buy?
- Kymera Therapeutics share price is 44.77 while KYMR 8-day exponential moving average is 46.22, which is a Sell signal.
- The stock price of KYMR is 44.77 while Kymera Therapeutics 20-day EMA is 45.92, which makes it a Sell.
- Kymera Therapeutics 50-day exponential moving average is 43.32 while KYMR share price is 44.77, making it a Buy technically.
- KYMR stock price is 44.77 and Kymera Therapeutics 200-day simple moving average is 36.21, creating a Buy signal.
Fundamental Analysis of Kymera Therapeutics
Is Kymera Therapeutics a good investment?
- Analysts estimate an earnings decrease this quarter of $0.15 per share, a decrease next quarter of $0.10 per share, a decrease this year of $0.25 per share, and a decrease next year of $0.51 per share.
Technical Analysis of Kymera Therapeutics
Should I short Kymera Therapeutics stock?
- KYMR Moving Average Covergence Divergence (MACD) indicator is 0.88, suggesting Kymera Therapeutics is a Buy
- Kymera Therapeutics Relative Strength Index (RSI) is 48.13, which suggest Kymera Therapeutics is oversold
- The Bollinger Bands (25) for Kymera Therapeutics is (43.03 - 48.09), which suggest Kymera Therapeutics is a Buy
- The Bollinger Bands (100) for Kymera Therapeutics is (32.8 - 44.58), which suggest Kymera Therapeutics is a Buy
* Kymera Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.